Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FICB for Pain Management in Hip Fracture
NCT02479828Completed
- Sponsor
- Asklepieion Voulas General Hospital
- Start
- Jun 2015
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain and chronic pain (2 arms), sponsored by Asklepieion Voulas General Hospital. Primary endpoints: Acute postsurgical pain after hip fracture surgery at 48 hours and Chronic postsurgical pain after hip fracture surgery at 6 months. Started Jun 2015; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative painchronic pain
Beyond the preview
Go deeper on NCT02479828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479828.